EMEA-000239-PIP01-08-M03 - paediatric investigation plan

Telavancin (hydrochloride)
PIPHuman

Key facts

Invented name
  • Vibativ
  • Vibativ
Active Substance
Telavancin (hydrochloride)
Therapeutic area
Infectious diseases
Decision number
P/0354/2017
PIP number
EMEA-000239-PIP01-08-M03
Pharmaceutical form(s)
Powder for concentrate for solution for infusion
Condition(s) / indication(s)
  • Treatment of nosocomial pneumonia
  • Treatment of complicated skin and soft tissue infections (cSSTI)
Route(s) of administration
Intravenous use
Contact for public enquiries

Theravance Biopharma Ireland Ltd.

Tel. +33 174882008
E-mail: marine.lafargue@quintilesims.com

Decision type
PM: decision on the application for modification of an agreed PIP
Decision date

Decision

Share this page